New Delhi: Drugs Controller General of India (DCGI) has allowed biotechnology company Panacea Biotec to manufacture Russia's Covid-19 vaccine Sputnik-V in India. The company said on Sunday that we are the first firm to manufacture this vaccine in India. Panacea Biotech is one of the six companies that partnered with Russia's Direct Investment Fund (RDIF), which is marketing the vaccine internationally.

Biotechnology company Panacea Biotech issued a statement saying that Panacea Biotech is in the process of obtaining a manufacturing licence from the Drug Controller General of India for Sputnik-V vaccine against the corona epidemic in collaboration with the Russian Direct Investment Fund. State that a license is an essential condition for using Sputnik-V made by Panacea Biotech in India.

The two-dose vaccine is 91.6 per cent effective against the corona epidemic. The first consignment of the Sputnik-V vaccine, manufactured by Panacea Biotech, was sent to the Gamalaya Center in Russia, where its quality control was checked. On the other hand, the company said that the first consignment made in Baddi has successfully passed all quality control tests at the Gamalaya Centre in Russia and the Central Drug Laboratory in India, Kasauli.

MY Hospital nursing staff's strike not over despite Govt's assurance

Mangaluru Animal Cruelty: Miscreant Kills Stray Dog With Air Gun

Owaisi replying to Mohan Bhagwat says 'this hatred is a gift of Hindutva, Digvijaya asked...'